Occlutech Atrial Flow Regulator

White Papers

2017 - Porcine model Poster

Jacek Baranowski, Henrik Ahn, Joseph J. Vettukattil

"Creation of a Predefined Interatrial Communication with the Occlutech® Atrial Flow Regulator: Outcomes in a Porcine Model"

2018 - The Atrial Flow Reducer (AFR) an interventional treatment for right heart failure (poster)

Ingram Schulze-Neick, Robert Dalla Pozza, Anja Lehner, Silvia Fernandez-Rodriguez, Anne Michalk, Beatrice Heineking, Claus Neurohr, Réné Schramm, and Nikolaus A. Haas

"The Atrial Flow Reducer (AFR): an interventional treatment for right heart failure due to increased pulmonary vascular resistance"

2018 - AFR in PH poster ACC

Joseph J. Vettukattil MBBS, MD, DNB, CCST, FRCPCH, FRSM, FRCP; Ramasamy Rajeshkumar; Nagib Dahdah; Dietmar Schranz; Ata Firouzi; Sven Dittrich; Daniel Springmüller; Vishal R. Kaley; Bennett P. Samuel; Kothandam Sivakumar Congenital Heart Center, Spectrum Health Helen DeVos Children’s Hospital, Grand Rapids, Michigan, USA

"Clinical Impact of Creating a Predetermined Atrial Communication in the Management of Severe Pulmonary Hypertension using the Atrial Flow Regulator Device"

2018 - Poster at PVRI

Joseph J. Vettukattil MBBS, MD, DNB, CCST, FRCPCH, FRSM, FRCP; Ramasamy Rajeshkumar MD, FNB; Nagib Dahdah MD; Dietmar Schranz MD; Ata Firouzi MD; Sven Dittrich MD; Daniel Springmüller MD; Vishal R. Kaley MBBS, MD; Bennett P. Samuel1 MHA, BSN, RN, Kothandam Sivakumar MD, DM Congenital Heart Center, Spectrum Health Helen DeVos Children’s Hospital, Grand Rapids, MI, USA Pediatrics and Human Development, Michigan State University College of Human Medicine, Grand Rapids, MI, USA

"Outcomes of Atrial Flow Regulator Implantation in Patients with Severe Pulmonary Hypertension"


The products shown may not be available in all markets. Availability for a specific therapeutic purpose, in any specific country or region, is subject to obtaining necessary regulatory clearance.